Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.9.2014 | EN | Official Journal of the European Union | C 292/43 |

---

Judgment of the General Court of 16 July 2014 — Endoceutics v OHIM — Merck (FEMIVIA)

(Case T-324/13)[(1)](#ntr1-C_2014292EN.01004302-E0001)

((Community trade mark - Opposition proceedings - Application for the Community word mark FEMIVIA - Earlier Community word mark FEMIBION - International registration designating the European Community of the earlier figurative mark femibion - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

2014/C 292/53

Language of the case: English

Parties

Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: P. Geroulakos, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court: Merck KGaA (Darmstadt, Germany) (represented by: M. Best, U. Pfleghar and S. Schäffner, lawyers)

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 15 April 2013 (Case R 1021/2012-4), concerning opposition proceedings between Merck KGaA and Endoceutics, Inc.

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Endoceutics, Inc. to pay the costs. |

---

[Top](#document1)